Tollovir (NLC-V-01)
/ Todos Medical
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
68
Go to page
1
2
3
December 12, 2025
An explainable imaging-clinical biomarker for non-small cell lung cancer prognostication based on normalised hotspot to centroid distance and [18F]FDG PET/CT radiomics.
(PubMed, Eur J Nucl Med Mol Imaging)
- "NHOC enhances NSCLC patient survival prediction, and when integrated with PET-CT radiomics and disease stage, offers a robust, non-invasive approach to disease prognostication."
Biomarker • Journal • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
August 13, 2025
Long COVID-related blood-brain barrier breakdown and microstructure in older adults are modified by sex and Alzheimer's disease genetic risk.
(PubMed, Imaging Neurosci (Camb))
- "Individuals with persistent cognitive complaints following SARS-CoV-2 infection (neurological long COVID, NLCV) and cognitively normal controls (50-90 years, 61% women) underwent neuropsychological evaluation, genotyping, dynamic contrast-enhanced MRI to measure BBB permeability, and multi-compartment diffusion MRI to measure brain microstructure...BBB dysfunction and microstructural compromise may contribute to cognitive symptoms of long COVID in older adults. Sex-specific patterns, and more deleterious associations between brain and memory abnormalities among individuals with elevated AD genetic risk, highlight the need for precision medicine diagnostic and therapeutic approaches for long COVID."
Journal • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Dementia • Infectious Disease • Inflammation • Novel Coronavirus Disease • Respiratory Diseases
March 10, 2023
"@G_Commish @todosmedical Please look into @tollovid #Tollovid #Tollovir #LongCovid #LongCovidAwarenessDay #LongCovidAwarenessMonth"
(@mauiboundad808)
Novel Coronavirus Disease
November 16, 2022
"@G_Commish maybe you should work with Munro & Associates to developed @todosmedical and raise the fund to launch #tollovir to the world ?"
(@GT14581438)
September 19, 2022
"@CathieDWood Please note root cause of US inflation intractibility is disabled workforce from #LongCOVID. @todosmedical $TOMDF sub #3CLPharma has supplement #Tollovid, drug #Tollovir & #TolloTest all targeting same mechanism as $PFE #Paxlovid @jonnajarian https://t.co/p7ZvhpUPsQ"
(@G_Commish)
Novel Coronavirus Disease
September 01, 2022
"Is @EricTopol even aware of #Tollovir ? Or is he just ignoring it?"
(@RandomD42250410)
August 30, 2022
"How about Tollovir and Tollovid by Todos Medical. Both products are better than anything Phizer has to offer."
(@L64Tiger)
July 24, 2022
"Tollovir is already way ahead as far as protease inhibitors for inpatient hospitalized patients in a capsule form. I expect an Israeli EUA this year."
(@TodosInvestor)
Clinical
June 24, 2022
"Good report. It seems to confuse the use of tollovid v. tollovir. Typical for TV editing."
(@Davidmeir657)
June 17, 2022
"Time to look at @todosmedical @tollovid #Tollovir @G_Commish !"
(@mauiboundad808)
June 01, 2022
"They can try Tollovid and Tollovir"
(@TigerL64)
May 30, 2022
Development of Tea Seed Oil Nanostructured Lipid Carriers and In Vitro Studies on Their Applications in Inducing Human Hair Growth.
(PubMed, Pharmaceutics)
- "In this study, tea seed oil loaded nanostructured lipid carriers (NLC) using Tween 80 (NLC-T), Varisoft 442 (NLC-V), and a combination of both surfactants (NLC-C) was developed...In conclusion, the developed NLC-C of tea seed oil is an effective alternative in stimulating hair growth. Hair serum containing NLC-C obviously reduces sticky, oily, and greasy feeling after use."
Journal • Preclinical • Alopecia
May 08, 2022
"Gerald is your product Paxlovid or Tollovir? Sometimes I wonder!"
(@Jose61439991)
May 05, 2022
"May I ask when you intend to start studying Tollovir on #longcovid ?"
(@LBrynvall)
Novel Coronavirus Disease
April 26, 2022
"@todosmedical is the answer for Covid. @G_Commish will show the world. #tollovid #tollovir"
(@AFazioMusic)
Novel Coronavirus Disease
April 13, 2022
"And Tollovir was our minor league prospect that was supposed to get us to the Playoffs(Nasdaq)."
(@FireGCTodos)
March 28, 2022
"$TOMDF CEO @G_Commish breaks down the IC50 levels in #Ivermectin which is 50, #Paxlovid 0.006, & #Tollovir 0.8. Ppl Taking #Ivermectin & saw benefits are not crazy. The lower the number, the tighter the binding to #3CL protease. https://t.co/4R2sMHUsOD #Antiviral #Tollovid"
(@todosmedical)
March 13, 2022
"There is a 3CLpro inhibitor you can buy on Amazon. @todosmedical Working on making @tollovid (currently supplement w/3CLpro inhibitor claim, not approved to diagnose treat prevent or cure any disease) OTC drug. Tollovir in Ph2 superior to Remdesivir $TOMDF https://t.co/0ard7zz3ht"
(@G_Commish)
March 04, 2022
"@G_Commish $tomdf @todosmedical time to step it up! lets get #tollovir to market!"
(@IKremenskiy)
March 04, 2022
"@todosmedical #tollovir is the way to go. plant based antiviral.."
(@IKremenskiy)
March 02, 2022
"https://t.co/Bnmnd6CVdN @todosmedical #tollovir"
(@strozillaa)
February 25, 2022
"Todos Medicals Tollovir needs EUA. https://t.co/Fu2VS4Qyns"
(@MarkBon66236173)
February 11, 2022
"$tomdf #tollovir @G_Commish @MarketRebels @petenajarian https://t.co/WPQAS0C8Yd"
(@JT9906134531)
February 08, 2022
"@todosmedical #Tollovid #Tollovir Look into their natural #antiviral It may help🤙🏾"
(@mauiboundad808)
February 07, 2022
Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19
(clinicaltrials.gov)
- P2 | N=31 | Completed | Sponsor: Todos Medical, Ltd.
New P2 trial • Infectious Disease • Novel Coronavirus Disease
1 to 25
Of
68
Go to page
1
2
3